Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...

Peripheral neuropathy is a common adverse effect of neurotoxic chemotherapy. In a randomized, double-blind clinical trial, an investigational hand therapy was not more effective at preventing ...

During a Case-Based Roundtable® event, Patrick M. Forde, MD, discussed safety and tolerability concerns with immunotherapy in ...

Figures in parentheses refer to results during the corresponding period of the previous yearThe Group's sales amounted to 64.8 (61.2) MSEK for the third quarter of the year.The Group's net result tota ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...

Scientists have designed a groundbreaking painkiller that activates solely at chronic pain sites, offering targeted, ...

Artelo Biosciences ( (ARTL) ) has released its Q3 earnings. Here is a breakdown of the information Artelo Biosciences presented to its ...

The National Comprehensive Cancer Network® (NCCN®)?an alliance of leading cancer centers?today announced the publication of a ...

Researchers have developed a non-addictive painkiller that remains inactive until it reaches sites of chronic pain. Instead of dulling the nerves that send the pain signals like other analgesics, this ...

Extensive testing in both chemical and preclinical models has demonstrated that this prodrug effectively provides targeted ...

Nauticus Robotics, Inc. , a leading innovator in subsea robotics and software, today announced its financial results for the quarter ended September 30, ...

Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect for patients undergoing cancer treatments, and ...